Your browser doesn't support javascript.
COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup.
Nadim, Mitra K; Forni, Lui G; Mehta, Ravindra L; Connor, Michael J; Liu, Kathleen D; Ostermann, Marlies; Rimmelé, Thomas; Zarbock, Alexander; Bell, Samira; Bihorac, Azra; Cantaluppi, Vincenzo; Hoste, Eric; Husain-Syed, Faeq; Germain, Michael J; Goldstein, Stuart L; Gupta, Shruti; Joannidis, Michael; Kashani, Kianoush; Koyner, Jay L; Legrand, Matthieu; Lumlertgul, Nuttha; Mohan, Sumit; Pannu, Neesh; Peng, Zhiyong; Perez-Fernandez, Xose L; Pickkers, Peter; Prowle, John; Reis, Thiago; Srisawat, Nattachai; Tolwani, Ashita; Vijayan, Anitha; Villa, Gianluca; Yang, Li; Ronco, Claudio; Kellum, John A.
  • Nadim MK; Division of Nephrology and Hypertension, Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Forni LG; Department of Clinical and Experimental Medicine, Faculty of Health Sciences, University of Surrey, Guildford, UK.
  • Mehta RL; Intensive Care Unit, Royal Surrey County Hospital NHS Foundation Trust, Guildford, UK.
  • Connor MJ; Division of Nephrology, Department of Medicine, University of California, San Diego, CA, USA.
  • Liu KD; Divisions of Pulmonary, Allergy, Critical Care, & Sleep Medicine, Division of Renal Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.
  • Ostermann M; Divisions of Nephrology and Critical Care Medicine, Departments of Medicine and Anesthesia, University of California, San Francisco, CA, USA.
  • Rimmelé T; Department of Intensive Care, Guy's & St Thomas' NHS Foundation Hospital, London, UK.
  • Zarbock A; Department of Anesthesiology and Intensive Care Medicine, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France.
  • Bell S; Department of Anesthesiology, Intensive Care and Pain Medicine, University Hospital Münster, Münster, Germany.
  • Bihorac A; Division of Population Health and Genomics, School of Medicine, University of Dundee, Dundee, UK.
  • Cantaluppi V; Department of Medicine, University of Florida, Gainesville, FL, USA.
  • Hoste E; Nephrology and Kidney Transplantation Unit, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
  • Husain-Syed F; Intensive Care Unit, Ghent University Hospital, Ghent University, Ghent, Belgium.
  • Germain MJ; Division of Nephrology, Pulmonology and Critical Care Medicine, Department of Medicine II, University Hospital Giessen and Marburg, Giessen, Germany.
  • Goldstein SL; Division of Nephrology, Renal Transplant Associates of New England, Baystate Medical Center U Mass Medical School, Springfield, MA, USA.
  • Gupta S; Division of Nephrology and Hypertension, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
  • Joannidis M; Division of Renal Medicine, Brigham and Women's Hospital, Boston, MA, USA.
  • Kashani K; Division of Intensive Care and Emergency Medicine, Department of Medicine, Medical University of Innsbruck, Innsbruck, Austria.
  • Koyner JL; Division of Nephrology and Hypertension, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
  • Legrand M; Division of Nephrology, Department of Medicine, University of Chicago, Chicago, IL, USA.
  • Lumlertgul N; Department of Anesthesiology and Perioperative Care, University of California San Francisco, San Francisco, CA, USA.
  • Mohan S; Department of Intensive Care, Guy's & St Thomas' NHS Foundation Hospital, London, UK.
  • Pannu N; Division of Nephrology, Excellence Center for Critical Care Nephrology, Critical Care Nephrology Research Unit, King Chulalongkorn Memorial Hospital, Chulalongkorn University, Bangkok, Thailand.
  • Peng Z; Department of Medicine, Division of Nephrology, Columbia University College of Physicians & Surgeons and New York Presbyterian Hospital, New York, NY, USA.
  • Perez-Fernandez XL; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA.
  • Pickkers P; Division of Critical Care Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.
  • Prowle J; Division of Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.
  • Reis T; Servei de Medicina Intensiva, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Srisawat N; Department of Intensive Care Medicine, Radboudumc, Nijmegen, The Netherlands.
  • Tolwani A; Critical Care and Peri-operative Medicine Research Group, William Harvey Research Institute, Queen Mary University of London, London, UK.
  • Vijayan A; Department of Nephrology, Dialysis and Transplantation, San Bortolo Hospital, International Renal Research Institute of Vicenza, Vicenza, Italy.
  • Villa G; Department of Nephrology, Clínica de Doenças Renais de Brasília, Brasília, Brazil.
  • Yang L; Division of Nephrology, Excellence Center for Critical Care Nephrology, Critical Care Nephrology Research Unit, King Chulalongkorn Memorial Hospital, Chulalongkorn University, Bangkok, Thailand.
  • Ronco C; Academy of Science, Royal Society of Thailand, Bangkok, Thailand.
  • Kellum JA; Division of Nephrology, Department of Medicine, University of Alabama, Birmingham, AL, USA.
Nat Rev Nephrol ; 16(12): 747-764, 2020 12.
Article in English | MEDLINE | ID: covidwho-872710
ABSTRACT
Kidney involvement in patients with coronavirus disease 2019 (COVID-19) is common, and can range from the presence of proteinuria and haematuria to acute kidney injury (AKI) requiring renal replacement therapy (RRT; also known as kidney replacement therapy). COVID-19-associated AKI (COVID-19 AKI) is associated with high mortality and serves as an independent risk factor for all-cause in-hospital death in patients with COVID-19. The pathophysiology and mechanisms of AKI in patients with COVID-19 have not been fully elucidated and seem to be multifactorial, in keeping with the pathophysiology of AKI in other patients who are critically ill. Little is known about the prevention and management of COVID-19 AKI. The emergence of regional 'surges' in COVID-19 cases can limit hospital resources, including dialysis availability and supplies; thus, careful daily assessment of available resources is needed. In this Consensus Statement, the Acute Disease Quality Initiative provides recommendations for the diagnosis, prevention and management of COVID-19 AKI based on current literature. We also make recommendations for areas of future research, which are aimed at improving understanding of the underlying processes and improving outcomes for patients with COVID-19 AKI.
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Renal Replacement Therapy / Acute Kidney Injury / COVID-19 Type of study: Diagnostic study / Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: Nat Rev Nephrol Journal subject: Nephrology Year: 2020 Document Type: Article Affiliation country: S41581-020-00356-5

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Renal Replacement Therapy / Acute Kidney Injury / COVID-19 Type of study: Diagnostic study / Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: Nat Rev Nephrol Journal subject: Nephrology Year: 2020 Document Type: Article Affiliation country: S41581-020-00356-5